Optimizing Active Surveillance

被引：8

作者：

Carter, H. Ballentine ^{[1
]}

机构：

[1] Johns Hopkins Univ, Sch Med, James Buchanan Brady Urol Inst, Baltimore, MD USA

来源：

EUROPEAN UROLOGY | 2016年 / 70卷 / 06期

关键词：

PROSTATE-CANCER; MEN; OUTCOMES; RISK;

D O I：

10.1016/j.eururo.2016.07.017

中图分类号：

R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：909 / 911

页数：3

共 10 条

[1] Precision Medicine in Active Surveillance for Prostate Cancer: Development of the Canary-Early Detection Research Network Active Surveillance Biopsy Risk Calculator [J].

Ankerst, Donna P. ;

Xia, Jing ;

Thompson, Ian M., Jr. ;

Hoefler, Josef ;

Newcomb, Lisa F. ;

Brooks, James D. ;

Carroll, Peter R. ;

Ellis, William J. ;

Gleave, Martin E. ;

Lance, Raymond S. ;

Nelson, Peter S. ;

Wagner, Andrew A. ;

Wei, John T. ;

Etzioni, Ruth ;

Lin, Daniel W. .

EUROPEAN UROLOGY, 2015, 68 (06) :1083-1088

[2] Aggressive care at the end-of-life for younger patients with cancer: Impact of ASCO's Choosing Wisely campaign. [J].

Chen, Ronald C. ;

Falchook, Aaron David ;

Tian, Fang ;

Basak, Ramsankar ;

Hanson, Laura ;

Selvam, Nandini ;

Dusetzina, Stacie .

JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (18)

[3] Upgrading and Downgrading of Prostate Cancer from Biopsy to Radical Prostatectomy: Incidence and Predictive Factors Using the Modified Gleason Grading System and Factoring in Tertiary Grades [J].

Epstein, Jonathan I. ;

Feng, Zhaoyong ;

Trock, Bruce J. ;

Pierorazio, Phillip M. .

EUROPEAN UROLOGY, 2012, 61 (05) :1019-1024

[4] Long-term Results of Active Surveillance in the Goteborg Randomized, Population-based Prostate Cancer Screening Trial [J].

Godtman, Rebecka Arnsrud ;

Holmberg, Erik ;

Khatami, Ali ;

Pihl, Carl-Gustaf ;

Stranne, Johan ;

Hugosson, Jonas .

EUROPEAN UROLOGY, 2016, 70 (05) :760-766

[5] Natural History of Early, Localized Prostate Cancer: A Final Report from Three Decades of Follow-up [J].

Popiolek, Marcin ;

Rider, Jennifer R. ;

Andren, Ove ;

Andersson, Sven-Olof ;

Holmberg, Lars ;

Adami, Hans-Olov ;

Johansson, Jan-Erik .

EUROPEAN UROLOGY, 2013, 63 (03) :428-435

[6] Active surveillance for prostate cancer: current evidence and contemporary state of practice [J].

Tosoian, Jeffrey J. ;

Carter, H. Ballentine ;

Lepor, Abbey ;

Loeb, Stacy .

NATURE REVIEWS UROLOGY, 2016, 13 (04) :205-215

[7] Intermediate and Longer-Term Outcomes From a Prospective Active-Surveillance Program for Favorable-Risk Prostate Cancer [J].

Tosoian, Jeffrey J. ;

Mamawala, Mufaddal ;

Epstein, Jonathan I. ;

Landis, Patricia ;

Wolf, Sacha ;

Trock, Bruce J. ;

Carter, H. Ballentine .

JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (30) :3379-+

[8] Pathological Outcomes in Men with Low Risk and Very Low Risk Prostate Cancer: Implications on the Practice of Active Surveillance [J].

Tosoian, Jeffrey J. ;

JohnBull, Eric ;

Trock, Bruce J. ;

Landis, Patricia ;

Epstein, Jonathan I. ;

Partin, Alan W. ;

Walsh, Patrick C. ;

Carter, H. Ballentine .

JOURNAL OF UROLOGY, 2013, 190 (04) :1218-1222

[9] Metastatic Prostate Cancer in Men Initially Treated with Active Surveillance [J].

Yamamoto, Toshihiro ;

Musunuru, Bindu ;

Vesprini, Danny ;

Zhang, Liying ;

Ghanem, Gabriella ;

Loblaw, Andrew ;

Klotz, Laurence .

JOURNAL OF UROLOGY, 2016, 195 (05) :1409-1414

[10] Novel Biomarker Signature That May Predict Aggressive Disease in African American Men With Prostate Cancer [J].

Yamoah, Kosj ;

Johnson, Michael H. ;

Choeurng, Voleak ;

Faisal, Farzana A. ;

Yousefi, Kasra ;

Haddad, Zaid ;

Ross, Ashley E. ;

Alshalafa, Mohammed ;

Den, Robert ;

Lal, Priti ;

Feldman, Michael ;

Dicker, Adam P. ;

Klein, Eric A. ;

Davicioni, Elai ;

Rebbeck, Timothy R. ;

Schaeffer, Edward M. .

JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (25) :2789-U108

← 1 →